February 27, 2017 by Chain Drug Review
Gianni Del Negro, Healthy Heart Clinic, London Drugs pharmacist
2017, Issue 02-27-2017, Issues, News
RICHMOND, British Columbia — London Drugs is helping raise public awareness of the preventive measures that can minimize the risk of heart disease by encouraging customers to attend a Healthy Heart Clinic at 68 of its locations. The program, which runs through March 23, is part of Heart Month in Canada, the western Canada drug
February 27, 2017 by Mark Baumgartner and Chain Drug Review
diabetes care, Healthy Outcomes Diabetes Support Program, RxMedSync, Thrifty White Pharmacy
2017, Issue 02-27-2017, Issues, News
PLYMOUTH, Minn. — Thrifty White Pharmacy has introduced the Healthy Outcomes Diabetes Support Program. Tailored to patients’ individual needs, the diabetes care solution is being offered directly to employers and through health plan partnerships. “We’ve continually heard from employers in our communities that diabetes is one of their top-two concerns,” Thrifty White said. “Our new
February 27, 2017 by Brian Bossetta
Cathy Magistrelli, Chris Skyers, Wakefern Food Corp.
2017, Issue 02-27-2017, Issues, News
KEASBEY, N.J. — There has been significant movement within the executive ranks at one of the largest retailer-owned cooperatives in the United States. On the heels of promoting Chris Skyers to vice president of corporate merchandising, Wakefern Food Corp. has now tapped Cathy Magistrelli as vice president of health and beauty care. Magistrelli joined Wakefern
February 27, 2017 by Scot Meyer and Chain Drug Review
B. Douglas Hoey, Consumer Healthcare Products Association, HHS secretary, National Association of Chain Drug Stores, National Community Pharmacists Association, Steve Anderson, Tom Price, U.S. Department of Health and Human Services
2017, Issue 02-27-2017, Issues, News
WASHINGTON — Vowing to fix what he called a “broken health care system,” Rep. Tom Price (R., Ga.) was sworn in earlier this month as secretary of the U.S. Department of Health and Human Services. Retail pharmacy groups responded by welcoming Price to his new post as HHS secretary. “We congratulate Rep. Tom Price on
February 27, 2017 by Mark Baumgartner and Chain Drug Review
Martin Sorrell, Stefano Pessina, Team WBA, Walgreens, Walgreens Boots Alliance, WPP
2017, Issue 02-27-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance has selected a dedicated agency team at WPP, the world’s largest marketing and advertising agency, to handle its global marketing and communications account. The drug store operator will work with Team WBA, a bespoke team of WPP agencies assigned to handle the retailer’s traditional and digital advertising, media buying
February 27, 2017 by Mark Baumgartner and Chain Drug Review
Amazon Prime Now, Amazon.com, Bartell Drugs, Brian Unmacht
2017, Issue 02-27-2017, Issues, News
SEATTLE — Amazon.com Inc. is expanding delivery of Bartell Drugs’ inventory to its Amazon Prime Now customers in the Greater Seattle area. The expansion was announced about 10 weeks after Amazon selected Bartells as the first drug store to sell merchandise through its Prime Now one- and two-hour delivery service. About 90% of Bartell’s inventory
February 27, 2017 by David Pinto and Chain Drug Review
chain drug industry, David Pinto, Rite Aid, Rite Aid acquisition, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 02-27-2017, Issues, Opinion
The major question in mass retailing this year, as the industry concludes the second month of 2017, is when — and indeed whether — Walgreens Boots Alliance’s acquisition of Rite Aid will be fruitfully concluded. As anyone who really cares knows by now the deadline for finalizing the Walgreens-Rite Aid merger has been extended to
February 27, 2017 by Jeffrey Woldt and Chain Drug Review
AmerisourceBergen, Andrew Mandzy, Bartell Drugs, Brian Owens, Doug Long, Jeffrey Woldt, Kantar Retail, Kristin Williams, Martin Otto, NACDS Regional Chain Conference, National Association of Chain Drug Stores, Nielsen, Peyton Howell, QuintilesIMS, regional drug chains, Steve Anderson, Thrifty White Pharmacy
2017, Issue 02-27-2017, Issues, Opinion
Although sometimes overlooked amid the swirl of activity surrounding the largest players in retail pharmacy, regional drug chains remain an integral part of the industry. The assets and aspirations of those companies — defined as operating between four and 250 stores — along with the challenges they face, were on display at the National Association
February 8, 2017 by Megan Moyer and Chain Drug Review
front-end strategies, Hamacher Resource Group, Megan Moyer, pharmacy customers
2017, Featured Articles, Issue 02-06-2017, Issues, Leading Headlines, Opinion
The front end of your stores holds great potential, and you have strategies in place to optimize those sales. But the industry shifts and changes every year. So it might be time to review those front-end strategies to ensure you are making the most of everything available to help improve the income generated in that
February 6, 2017 by Greg Jacobson and Chain Drug Review
Affordable Care Act, Bill Cassidy, Chuck Schumer, Kellyanne Conway, Obamacare, Obamacare Replacement Act, Patient Freedom Act of 2017, President Donald Trump, Rand Paul, repeal the ACA, Susan Collins
2017, Issue 02-06-2017, Issues, News
WASHINGTON — In his first executive order after taking office, President Donald Trump ordered federal agencies to waive or delay any provisions of the Affordable Care Act they consider onerous to individuals, states or insurers. The order contained few specifics, however, and raised more questions about the fate and direction of the country’s health care
February 6, 2017 by Geoff Walden and Chain Drug Review
CVS Health, David Denton, Edith Ramirez, Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Stefano Pessina, Terrell McSweeny, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 02-06-2017, Issues, News
WASHINGTON — The acquisition of Rite Aid Corp. by Walgreens Boots Alliance (WBA) Inc. remained unconsummated after WBA’s plan to divest 865 stores failed to erase antitrust regulators’ competitive concerns. When the Friday, January 27, deadline for completing the Walgreens-Rite Aid merger deal arrived, the Federal Trade Commission still hadn’t cleared the transaction, despite the
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Aetna, Aetna-Humana merger, Affordable Care Act, Anthem-Cigna merger, Bruce Broussard, health insurers, Humana, Mark Bertolini, Medicare Advantage
2017, Issue 02-06-2017, Issues, News
WASHINGTON — A federal judge last month temporarily blocked Aetna Inc.’s proposed acquisition of Humana Inc. The move stemmed from a ruling on a lawsuit brought last year by the Justice Department to prevent the health insurers from merging on the grounds that the deal would produce higher prices for consumers and fewer services for
February 6, 2017 by Scot Meyer and Chain Drug Review
Adrenaclick, Amedra Pharmaceuticals, CVS Health, CVS Pharmacy, Douglas Boothe, epinephrine auto-injector, EpiPen, Helena Foulkes, Impax Laboratories, mylan
2017, Issue 02-06-2017, Issues, News
WOONSOCKET, R.I. — CVS Health is providing a low-cost alternative Mylan’s EpiPen epinephrine auto-injector for anaphylaxis. CVS has made Impax Laboratories’ epinephrine auto-injector available at all CVS Pharmacy drug stores at a cash price of $109.99 for a two-pack. That compares with a cash price of $649.99 for the branded EpiPen and $339.99 for the
February 6, 2017 by Scot Meyer and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HHS secretary, Orrin Hatch, Tom Price, Trump administration
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Tom Price, an orthopedic surgeon, a six-term Republican congressman from Georgia and a fierce critic of the Affordable Care Act, faced tough questions from Democrats about ethical issues and policy priorities during his confirmation hearing. But at presstime it appeared that he would be approved as Secretary of the Department of Health and